Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 86 700 KRW -0.57%
Market Cap: 1.2T KRW

Intrinsic Value

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is hidden KRW. Compared to the current market price of 86 700 KRW, Chong Kun Dang Pharmaceutical Corp is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Chong Kun Dang Pharmaceutical Corp Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Chong Kun Dang Pharmaceutical Corp

Intrinsic Value History
Dive into the past to invest in the future

Chong Kun Dang Pharmaceutical Corp looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Chong Kun Dang Pharmaceutical Corp usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Chong Kun Dang Pharmaceutical Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Chong Kun Dang Pharmaceutical Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Chong Kun Dang Pharmaceutical Corp.

Explain Valuation
Compare Chong Kun Dang Pharmaceutical Corp to

Fundamental Analysis

Chong Kun Dang Pharmaceutical Corp
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Chong Kun Dang Pharmaceutical Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chong Kun Dang Pharmaceutical Corp

Current Assets 963.4B
Cash & Short-Term Investments 224B
Receivables 330.9B
Other Current Assets 408.4B
Non-Current Assets 538.4B
Long-Term Investments 81.4B
PP&E 327.1B
Intangibles 82.5B
Other Non-Current Assets 47.4B
Current Liabilities 390.9B
Accounts Payable 199.6B
Accrued Liabilities 14.5B
Short-Term Debt 91B
Other Current Liabilities 85.9B
Non-Current Liabilities 198.4B
Long-Term Debt 106.6B
Other Non-Current Liabilities 91.8B
Efficiency

Free Cash Flow Analysis
Chong Kun Dang Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Chong Kun Dang Pharmaceutical Corp

Revenue
1.7T KRW
Cost of Revenue
-1.1T KRW
Gross Profit
519.2B KRW
Operating Expenses
-450.3B KRW
Operating Income
68.9B KRW
Other Expenses
-7.9B KRW
Net Income
61B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chong Kun Dang Pharmaceutical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Positive 3Y Average ROIC
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
hidden
Profitability
Score

Chong Kun Dang Pharmaceutical Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chong Kun Dang Pharmaceutical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
hidden
Solvency
Score

Chong Kun Dang Pharmaceutical Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chong Kun Dang Pharmaceutical Corp

Wall Street analysts forecast Chong Kun Dang Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chong Kun Dang Pharmaceutical Corp is 117 300 KRW with a low forecast of 101 000 KRW and a high forecast of 141 750 KRW.

Lowest
Price Target
101 000 KRW
16% Upside
Average
Price Target
117 300 KRW
35% Upside
Highest
Price Target
141 750 KRW
63% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Chong Kun Dang Pharmaceutical Corp is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Chong Kun Dang Pharmaceutical Corp stock?

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is hidden KRW.

Is Chong Kun Dang Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 86 700 KRW, Chong Kun Dang Pharmaceutical Corp is hidden .

Back to Top